Literature DB >> 2851647

Glioblastoma in the older patient: how long a course of radiotherapy is necessary?

J Newall1, J Ransohoff, B Kaplan.   

Abstract

Eighteen patients over 60 years old with a histologically proven diagnosis of glioblastoma multiforme were treated by a short radiotherapy course (3000 cGy midline dose by two opposed portals to the whole brain). Results in terms of survival and function appeared to be as good as with the standard course of six to seven weeks as reported in the literature.

Entities:  

Mesh：

Year:  1988        PMID： 2851647     DOI： 10.1007/bf00177427

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  4 in total

1.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

2.  Assumptions in the radiotherapy of glioblastoma.

Authors:  F H Hochberg; A Pruitt
Journal:  Neurology       Date:  1980-09       Impact factor: 9.910

3.  Malignant glioma. Results of combined modality therapy.

Authors:  J S Cooper; T L Borok; J Ransohoff; R J Carella
Journal:  JAMA       Date:  1982-07-02       Impact factor: 56.272

4.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.

Authors:  C H Chang; J Horton; D Schoenfeld; O Salazer; R Perez-Tamayo; S Kramer; A Weinstein; J S Nelson; Y Tsukada
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860
  4 in total
  8 in total

1.  Pre-radiation chemotherapy in glioma patients with poor prognostic factors.

Authors:  K Watne; O Nome; B Hager; H Hirschberg
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

Review 2.  The treatment of primary malignant brain tumours.

Authors:  I R Whittle; A Gregor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

3.  Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.

Authors:  L Fariselli; V Pinzi; I Milanesi; A Silvani; M Marchetti; M Farinotti; A Salmaggi
Journal:  Strahlenther Onkol       Date:  2013-04-28       Impact factor: 3.621

4.  A prospective study of short course radiotherapy in elderly patients with malignant glioma.

Authors:  D B Hoegler; P Davey
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

5.  Treatment of malignant gliomas in the elderly.

Authors:  J Y Pierga; K Hoang-Xuan; L Feuvret; J M Simon; P Cornu; F Baillet; J J Mazeron; J Y Delattre
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

6.  Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study.

Authors:  B Jeremic; Y Shibamoto; D Grujicic; B Milicic; M Stojanovic; N Nikolic; A Dagovic; J Aleksandrovic
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

7.  Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

Authors:  Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

8.  Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.

Authors:  B Jeremic; D Grujicic; V Antunovic; L Djuric; M Stojanovic; Y Shibamoto
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.